We recently reported that the BA-mediated inhibition of multiple deubiquitinases (DUBs), increase in poly-Ub proteins, decrease in multiple pro-survival proteins, and induction of apoptotic cell death specifically in PCa but not in non-cancer cells could provide an effective non-toxic and clinically selective agent for chemotherapy [26]. The gene discussed is PROS1; the disease is cancer.